期刊文献+

血液病房细菌耐药监测 被引量:11

Surveillance of Bacterial Resistance in Hematology Ward
暂未订购
导出
摘要 目的了解血液病房患者分离菌的分布和耐药特征,指导临床合理使用抗菌药物。方法采用纸片扩散法(K-B法)对我院血液病房患者中分离的397株细菌进行药敏试验,并用WHONET5.3进行分析。结果397株细菌中革兰阴性杆菌为65.2%,革兰阳性球菌为34.8%;革兰阴性杆菌中肠杆菌科细菌为55%,非发酵菌为44%;革兰阳性球菌中葡萄球菌属为60.8%,其中金黄色葡萄球菌26.2%,凝固酶阴性葡萄球菌73.8%;肠球菌属38.4%;大肠埃希菌ESBLs的检出率为55.8%,克雷伯菌中ESBLs的检出率为19.2%;金黄色葡萄球菌MRSA的检出率为40.9%,凝固酶阴性葡萄球菌MRCNS的检出率为95.2%。结论通过对细菌的耐药监测和分析了解各病原菌的耐药特点和机制,指导临床早期经验性用药。 OBJECTIVE To investigate the epidemic characteristics and drug resistance profile of clinical bacteria in hematology ward of our hospital, METHODS The susceptibility testing of clinical isolates from hematology ward was performed and the ESBLs producing strains were detected using K-B method. The results were analyzed by WHONET5. RESULTS Out of the 397 clinical isolates, 65.2% were Gram-negative bacilli and 34. 8% were Gram-positive cocci. In Gram-negative bacilli, 55% were Enterobacteriaceae and 44% were nonfermenting Gram- negative bacilli. In Gram-positive cocci, 60.8% were Staphylococcus spp and 38.4% were Enterococcus spp. The ESBLs producing strains in Escherichia coli and Klebsiella spp were 55.8% and 19. 2%, respectively. The MRSA in S. aureus and MRCNS in coagulase negative Staphylococcus were 40. 9% and 95.2%, respectively. No resistance to earhapenem was detected in Enterohacteriaceae and no resistance to vaneomyein was detected in Gram-positive cocci. The resistance rate of nonfermenting Gram-negative bacilli to cefoperazone/sulbaetam .was less than 2.1%. CONCLUSIONS The data will be useful for the early empiric administration of antimicrobial agent in hematology ward.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2006年第2期206-208,217,共4页 Chinese Journal of Nosocomiology
关键词 血液病房 革兰阴性杆菌 革兰阳性球菌 细菌耐药性 Hematology ward Gram-negative bacilli Gram-positive cocci Drug resistance
  • 相关文献

参考文献5

二级参考文献35

  • 1朱德妹,汪复,胡付品,吴湜,张婴元.2002年上海地区医院细菌耐药性监测[J].中华传染病杂志,2004,22(3):154-159. 被引量:63
  • 2熊自忠,朱德妹,汪复,张婴元.CTX-M-14和CTX-M-24编码基因的检测及其功能表达[J].中华医学杂志,2004,84(17):1454-1459. 被引量:15
  • 3汪复,朱德妹,张婴元.上海部分医院细菌耐药性监测及其临床意义[J].中华传染病杂志,1996,14(3):148-151. 被引量:101
  • 4National Committee for Clinical Laboratory Standards, Performance Standards for Antimicrobial Susceptibility Testing,Twelfth Informational Supplement[S]. 2003 ,M100-S13.
  • 5Jae-Hoon Song. Pneumococcal Resistance to Beta-Lactams and Macrolides[C]. International Symposium on Antimicrobial Agents and Resistance, 2003,30-33.
  • 6Center for diseases prevention &epidemiology. oregon health division. Vancomycin-resistant enterococcal infections[J]. C D summary, 1997,46:1.
  • 7EARSS Annual Report 2002[EB/OL]. http://www. earss.rivm. nl.
  • 8Wang H, KelKar S, Wu W, etal, Clinical isolates of Enterobacteriaceae producing extended-spectrum beta-lactamases:prevalence of CTX-M-3 at a hospital in China[J]. Antimicrob Agents chemother, 2003,47: 790-793.
  • 9Chanawong A,MZali FH, Heritage J. et al. Three cefortaximases, CTX-M-9, CTX-M-13 and CTX-M-14, among Enterobacteriaceae in the People's Republic of China[J]. Antimicrob Agents Chemother, 2002,46: 630-637.
  • 10Kliebe C,Nies BA, Meyer JF, et al. Evolution of plasmid-coded resistance to broad-spectrum cephalosporins[J]. Antimicrob Agents Chemother, 1985, 28: 302-307

共引文献219

同被引文献70

引证文献11

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部